Stem Cell Research Investment Act of 2005

Summary

Stem Cell Research Investment Act of 2005 - Amends the Internal Revenue Code to allow a tax credit for investment in qualified stem cell research bonds. Defines "qualified stem cell research bond" as any bond issued by a State or local government, 95 percent of the proceeds of which are to be used for interdisciplinary scientific and medical research relating to stem cells, therapy development relating to stem cells, and development of pharmacologies and treatments through clinical trials relating to stem cells. Imposes certain limitations on the use of stem cells that are supported by a bond issuance under this Act. Sets a national limitation in 2006 through 2008 of $10 billion on the issuance of stem cell research bonds. Terminates the authority to issue such bonds after FY 2008.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 14 April 2005

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 14 April 2005

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 14 April 2005

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.